Co., Inc. (NYSE:MRK), recently purchased 2,832.861 shares of the company's common stock. The acquisition, valued at approximately $249,999, was completed at a price of $88.25 per share. Following this ...
Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...
Shares of Merck & Co. Inc. MRK slid 1.81% to $88.05 Thursday, on what proved to be an all-around mixed trading session for ...
The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in ...
BofA analyst Michael Feniger raised the firm’s price target on Cummins (CMI) to $394 from $358 and keeps a Neutral rating on the shares. 2025 ...
- LabConnect anuncia la formación de un Consejo Asesor Estratégico y el nombramiento de sus miembros inaugurales Personalised advertising and content, advertising and content measurement, audience ...
LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the formation of its ...